Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-26

Clinical Trial Update: Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers

View source ↗

Summary

A completed clinical trial evaluated whether prescription of 5-alpha-reductase inhibitors is associated with higher-grade prostate cancers in men with benign pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)
  • FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: Rennes University Hospital | Conditions: Benign Prostate Hyperplasia | Status: COMPLETED